World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Potential for Deals Drives a Big Surge in the Biotech Sector
Keywords:
Tags: Pharmaceutical,
U.S. Biotech IPO's 2011-2015
05/12/2013
Grouped Articles
Wall Street Journal 07/01/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
IPOs Set to Raise Most Cash Since Crisis
Wall Street Journal 05/12/2013
Wall Street Journal 07/01/2013
Opening the Box on Tech Stocks' Next Move
Wall Street Journal 04/10/2014
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
Abbott and biotech drugs
01/13/2011
Grouped Articles
Wall Street Journal 07/01/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
Abbott Is Challenging Biotech Drug Copies
Wall Street Journal 06/21/2012
Wall Street Journal 01/13/2011
Biotech pharmaceutical companies and industry.
03/14/2007
Grouped Articles
Wall Street Journal 07/01/2013
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12/16/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
For Booming Biotech Firms, A New Threat: Generics
Wall Street Journal 03/14/2007
BusinessWeek 04/09/2007
China's Biotech companies
01/13/2011
Grouped Articles
Wall Street Journal 07/01/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
A New Cancer Drug, Made in China
Wall Street Journal 04/03/2015
As U.N. Meets, a Battle Over Generic Biotech Drugs
New York Times 09/18/2011
Wall Street Journal 01/13/2011
The development of Biosimilar Drugs (copies of Biotech Drugs)
11/22/2010
Grouped Articles
Wall Street Journal 07/01/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Pharmaceutical Industry Is Facing Biological Warfare
Wall Street Journal 11/22/2010
Biotech Drugs Still Won't Copy
Wall Street Journal 02/27/2013
U.S. biotech companies and industry
01/13/2011
Grouped Articles
Wall Street Journal 07/01/2013
Wall Street Journal 07/01/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Wall Street Journal 07/25/2015
Wall Street Journal 09/29/2015
Wall Street Journal 11/22/2011
Biotech companies and efforts to limit generics
01/28/2013
Higher pricing would reduce savings from health care reforms.
Grouped Articles
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
Biotech Firms, Billions at Risk, Lobby States to Limit Generics
New York Times 01/28/2013
Biotechs comeback in 2012-2014
07/01/2013
Grouped Articles
Wall Street Journal 07/01/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
Wall Street Journal 07/25/2015
Wall Street Journal 09/29/2015
India's Biotech companies
01/13/2011
Makers of insulin and other biotech companies in India.
Grouped Articles
Wall Street Journal 07/01/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
From Brewing, an Indian Biotech Is Born
BusinessWeek 02/24/2011
As U.N. Meets, a Battle Over Generic Biotech Drugs
New York Times 09/18/2011
Why India should scare Silicon Valley - The Washington Post
Washington Post 11/29/2011
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us